Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine

Annals of Neurology

Volumn 62, Issue 1, 2007, Pages 21-33

  Black, Joel A ^a,b   Liu, Shujun ^a,b   Carrithers, Michael ^a   Carrithers, Lisette M ^a   Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MODEL; DRUG EFFECT; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; ANTIGENS, CD; AXONS; CARBAMAZEPINE; CELL COUNT; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PHENYTOIN; PYRAMIDAL TRACTS; SEVERITY OF ILLNESS INDEX; SODIUM CHANNELS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34547773583     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21172     Document Type: Article

References (40)

1. DeStefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121:1469-1477.
2. Bjartmar C, Kidd G, Mork S, et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetylaspartate in chronic multiple sclerosis patients. Ann Neurol 2000;48:893-901.
3. 24 exchanger. J Neurosci 1992;12:430-439.
4. Stys PK, Ransom BR, Waxman SG. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992;67:236-240.
5. Fern R, Ransom BR, Stys PK, Waxman SG. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine, and diazepam. J Pharmacol Exp Ther 1993;266:1549-1555.
6. 2+-dependent injury of the dorsal columns. J Neurotrauma 1997;14:299-311.
7. Kapoor R, Davies M, Blaker PA, et al. Blockers of sodium and calcium entry protect axons from nitric-oxide mediated degeneration. Ann Neurol 2003;53:174-180.
8. Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 2003;90:3566-3571.
9. Black JA, Liu S, Hains BC, et al. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 2006;129:3196-3208.
10. Bechtold DA, Kapoor R, Smith KJ. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 2004;55:607-616.
11. Bechtold DA, Miller SJ, Dawson AC, et al. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol 2006;253:1542-1551.
12. Eugster H-P, Frei K, Kopf M, et al. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol 1998;28:2178-2187.
13. Brabb T, von Dassow P, Ordonez N, et al. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J Exp Med 2000;192:871-880.
14. Carrithers MD, Tandon S, Canosa S, et al. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 2005;166:185-196
15. Craner MJ, Damarjian TG, Liu S, et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 2005;49:220-229.
16. + channel activity. FEBS Lett 2004;569:191-194.
17. Sedgwick JD, Schwender S, Imrich H. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 1991;88:7438-7442.
18. Hathcock KS, Hirano H, Murakami S, et al. CD45 expression by B cells. Expression of different CD45 isoforms by subpopulations of activated B cells. J Immunol 1992;149:2286-2294.
19. Leo O, Foo M, Sachs DH, et al. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A 1987;84:1374-1378.
20. Pierres A, Naquet P, Van Agthoven A, et al. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. J Immunol 1984;132:2775-2782.
21. Takahashi K, Nakata M, Tanaka T, et al. CD4 and CD8 regulate interleukin 2 responses of T cells. Proc Natl Acad Sci U S A 1992;89:5557-5561.
22. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004;75:388-397.
23. Lovas G, Szilagyi N, Majtenyi K, et al. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000;123:308-317.
24. Korotzer AR, Cotman CW. Voltage-gated currents expressed by rat microglia in culture. Glia 1998;6:81-88.
25. Norenberg W, Illes P, Gebicke-Haerter PJ. Sodium channels in isolated human brain macrophages (microglia). Glia 1994;10:165-172.
26. Schmidtmayer J, Jacobsen C, Miksch G, et al. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: membrane currents. Glia 1994;12:259-267.
27. Eder C. Ion channels in microglia (brain macrophages). Am J Physiol 1998;275:C327-C342.
28. DeCoursey TE, Chandy KG, Gupta S, et al. Voltage-dependent ion channels in T-lymphocytes. J Neuroimmunol 1985;10:71-95.
29. Gallin EK. Ion channels in leukocytes. Physiol Rev 1991;71:775-811.
30. Roselli F, Livrea P, Jirillo E. Voltage-gated sodium channel blockers as immunomodulators. Rec Patents in CNS Drug Discov 2006;1:83-91.
31. Margaretten NC, Hincks JR, Warren RP, et al. Effects of phenytoin and carbamazepine on human natural killer cell activity and genotoxicity in vitro. Toxicol Appl Pharmacol 1987;87:10-17.
32. Andrade-Mena CE, Sardo-Olmedo JAJ, Ramirez-Lizardo EJ. Effects of phenytoin administration on murine immune function. J Neuroimmunol 1994;50:3-7.
33. Okamoto Y, Shimizu K, Tamura K, et al. Effects of phenytoin on cell-mediated immunity. Cancer Immunol Immunother 1988;26:176-179.
34. Yamada M, Ohkawa M, Tamura K, et al. Anticonvulsant-induced suppression of IFN-γ production by lymphocytes obtained from cervical lymph nodes in glioma-bearing mice. J Neuro-Oncol 2000;47:125-132.
35. Gordienko DV, Tsukahara H. Tetrodotoxin-blockade depolarization-activated Na+ currents in a cultured endothelial cell line derived from rat interlobar artery and human umbilical ven. Pflugers Arch 1994;428:91-93.
36. Gosling M, Harley SL, Turner RJ, et al. Human saphenous vein endothelial cells express a tetrodotoxin-resistant, voltage-gated sodium current. J Biol Chem 1998;273:21084-21090.
37. Walsh KB, Wolf, WB, Fan J. Voltage-gated sodium channels in cardiac microvascular endothelial cells. Am J Physiol 1998;274:H506-H512.
38. Traub O, Ishida T, Ishida M, et al. Shear stress-mediated extracellular signal-regulated kinase activation is regulated by sodium in endothelial cells. J Biol Chem 1999;274:20144-20150.
39. McDonald WI. The time course of conduction failure during degeneration of a central tract. Exp Brain Res 1972;14:550-556.
40. Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002;1:232-241.